Wockpharma For Swing/Positional
Updated
Wockpharma (Wockhardt) Prediction for Swing/ Posional Trading
Breakout at entry 1 (254) level. Entry 2 is above 270 .It can retest entry 2 level , even entry 1 level. You can enter into trade at CMP or after retest.
Sls- according to you RRR.
Targets- 280,292,303,314,325,335,346,358,370,382,… (more will be updated later if need )
According to your “STOMACH” book your profit. Always maintain your risk management.
Watch Carefully – The Chart Explains For Itself.
Disclaimer:
I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade.
Happy trading.
About Wockpharma (Wockhardt) –
Wockhardt Ltd. engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.
Breakout at entry 1 (254) level. Entry 2 is above 270 .It can retest entry 2 level , even entry 1 level. You can enter into trade at CMP or after retest.
Sls- according to you RRR.
Targets- 280,292,303,314,325,335,346,358,370,382,… (more will be updated later if need )
According to your “STOMACH” book your profit. Always maintain your risk management.
Watch Carefully – The Chart Explains For Itself.
Disclaimer:
I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade.
Happy trading.
About Wockpharma (Wockhardt) –
Wockhardt Ltd. engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.
Comment
270 to 630 (High)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.